James William Ogilvie
Physician in Salt Lake City, UT

License number
Utah 150764-1205
Issued Date
Nov 25, 1969
Expiration Date
Jan 31, 2018
Category
Physician
Type
Physician & Surgeon
Address
Address
Salt Lake City, UT

Personal information

See more information about James William Ogilvie at radaris.com
Name
Address
Phone
James Ogilvie, age 84
40 N State St APT 4E, Salt Lake City, UT 84103
(801) 929-9669
James Ogilvie, age 38
2841 E 2100 S, Salt Lake City, UT 84109
(801) 942-5482
James Ogilvie
3664 2200 W, Salt Lake City, UT 84119
James W Ogilvie
40 N State St, Salt Lake City, UT 84103
(801) 364-7118
James W Ogilvie, age 84
40 State St, Salt Lake Cty, UT 84103
(801) 364-7118

Professional information

James Ogilvie Photo 1

Consultant At Taueret Laboratories

Position:
Consultant at Lucina Foundation
Location:
Greater Salt Lake City Area
Industry:
Research
Work:
Lucina Foundation - Salt Lake City, UT since Nov 2012 - Consultant University of Minnesota - School of Medicine Jul 1982 - Nov 2003 - Professor emeritus, Department of Orthopaedic Surgery
Education:
Yale University School of Medicine
Doctor of Medicine (MD)
Interests:
Genetics of spinal disease, Rocky Mountain wildflowers, cosmology, skiing


James W Ogilvie Photo 2

Dr. James W Ogilvie - MD (Doctor of Medicine)

Procedures:
Anterior Cruciate Ligament (Acl) Surgeries, Arthrocentesis, Arthroplasty, Arthroscopy, Aspiration, Carpal Tunnel Release, Cortisone Injection, Discectomy, Endoscopic Therapy, Endoscopy
Hospitals:
1340 East Pl NORTH, Salt Lake City 84103
1340 East Pl NORTH, Salt Lake City 84103
Education:
Medical Schools
Yale University
Graduated: 1968


James Ogilvie Photo 3

James Ogilvie, Salt Lake City UT

Work:
Shriner Hospital For Children
1340 E 300 N, Salt Lake City, UT Park Nicollet Health Services
3800 Park Nicollet Blvd, Minneapolis, MN 55416


James Ogilvie Photo 4

Devices And Methods For Correcting Spinal Deformities

US Patent:
2011019, Aug 4, 2011
Filed:
Feb 1, 2011
Appl. No.:
13/018482
Inventors:
James W. Ogilvie - Brighton UT, US
Assignee:
WARSAW ORTHOPEDIC, INC. - Warsaw IN
International Classification:
A61B 17/88
US Classification:
606279
Abstract:
The present application discloses methods for treating a spinal deformity. In one embodiment, an elongated member is attached to vertebral members with fasteners. A separate fastener may attach the elongated member to each of the vertebral members. The elongated member may apply a force to limit growth on one side of the vertebral members, such as a convex side of a scoliotic spine. Each fastener may be constructed to limit a direction of growth of the vertebral member thereby applying a specific, corrective force to the vertebral member. The fasteners may allow relative motion between adjacent vertebral members without losing the attachment between the vertebral members and the fasteners. The net result may be controlled modulation of growth to reduce and/or eliminate the spinal deformity through redirection of growth potential.


James Ogilvie Photo 5

Simplified Method Of Determining Predisposition To Scoliosis

US Patent:
2013031, Nov 21, 2013
Filed:
Mar 22, 2013
Appl. No.:
13/848772
Inventors:
Michael R. Schramm - Perry UT, US
James W. Ogilvie - Brighton UT, US
Lesa M. Nelson - Park City UT, US
Kenneth Ward - Salt Lake City UT, US
Rakesh N. Chettier - Salt Lake City UT, US
International Classification:
C12Q 1/68, G06F 19/00
US Classification:
506 2, 702 19
Abstract:
The present invention relates to novel genetic markers associated with scoliosis, risk of developing scoliosis and risk of scoliosis curve progression, and simplified methods and materials for determining whether a human subject has scoliosis, is at risk of developing scoliosis or is at risk of scoliosis curve progression.


James Ogilvie Photo 6

Method Of Determining Predisposition To Scoliosis

US Patent:
2012025, Oct 11, 2012
Filed:
Jun 19, 2012
Appl. No.:
13/526876
Inventors:
Michael R. Schramm - Perry UT, US
James W. Ogilvie - Brighton UT, US
Lesa M. Nelson - Park City UT, US
Kenneth Ward - Salt Lake City UT, US
Rakesh N. Chettier - West Jordan UT, US
Assignee:
AXIAL BIOTECH, INC. - Salt Lake City UT
International Classification:
C12Q 1/68, G06F 19/00, C40B 30/04
US Classification:
506 9, 435 611, 702 19
Abstract:
The present invention relates to novel genetic markers associated with scoliosis, risk of developing scoliosis and risk of scoliosis curve progression, and simplified methods and materials for determining whether a human subject has scoliosis, is at risk of developing scoliosis or is at risk of scoliosis curve progression.


James Ogilvie Photo 7

Method Of Determining Predisposition To Scoliosis

US Patent:
2013028, Oct 31, 2013
Filed:
Mar 28, 2013
Appl. No.:
13/852932
Inventors:
Michael R. Schramm - Perry UT, US
James W. Ogilvie - Brighton UT, US
Lesa M. Nelson - Park City UT, US
Kenneth Ward - Salt Lake City UT, US
Rakesh N. Chettier - West Jordan UT, US
International Classification:
C12Q 1/68
US Classification:
506 9, 435 611
Abstract:
The present invention relates to novel genetic markers associated with scoliosis, risk of developing scoliosis and risk of scoliosis curve progression, and simplified methods and materials for determining whether a human subject has scoliosis, is at risk of developing scoliosis or is at risk of scoliosis curve progression.


James Ogilvie Photo 8

Method Of Treating Scoliosis Using A Biological Implant

US Patent:
8641738, Feb 4, 2014
Filed:
Jan 25, 2012
Appl. No.:
13/357800
Inventors:
James W. Ogilvie - Brighton UT, US
Kenneth Ward - Salt Lake City UT, US
Lesa M. Nelson - Park City UT, US
International Classification:
A61B 17/88
US Classification:
606279
Abstract:
The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.


James Ogilvie Photo 9

Method Of Treating Scoliosis Using A Biological Implant

US Patent:
8123787, Feb 28, 2012
Filed:
Dec 22, 2008
Appl. No.:
12/341289
Inventors:
James W. Ogilvie - Brighton UT, US
Kenneth Ward - Salt Lake City UT, US
Lesa M. Nelson - Park City UT, US
International Classification:
A61B 17/88
US Classification:
606279
Abstract:
The present invention is a bone growth stimulating and promoting cytokine type biological implant preferably comprising PTH coated with a controlled release biodegradable coating that is implanted preferably in the concave side of a scoliotically curved spine in combination with a bone growth inhibiting type biological implant preferably comprising methotrexate or like anti-metabolite coated with a controlled release biodegradable coating that is implanted preferably in the convex side of a scoliotically curved spine. The insertion of the biological implant is highly non-invasion, especially as compared to more conventional spine surgical methods, and the biological implant does not decrease spinal mobility or spinal range of motion.


James Ogilvie Photo 10

Genetic Markers Associated With Degenerative Disc Disease And Uses Thereof

US Patent:
2010000, Jan 7, 2010
Filed:
Jul 1, 2009
Appl. No.:
12/496642
Inventors:
Rakesh N. Chettier - Salt Lake City UT, US
Lesa M. Nelson - Park City UT, US
Kenneth Ward - Salt Lake City UT, US
James W. Ogilvie - Brighton UT, US
Roberto A. Macina - San Jose CA, US
Assignee:
Axial Biotech, Inc. - Salt Lake City UT
International Classification:
C12Q 1/68, C07H 21/04, C40B 60/12
US Classification:
435 6, 536 2431, 536 2433, 506 39
Abstract:
The present invention relates to novel genetic markers associated with degenerative disc disease (DDD), risk of developing DDD and risk of DDD progression, and methods and materials for determining whether a human subject has DDD, is at risk of developing DDD or is at risk of DDD progression.